T45.0X2 Poisoning by antiallergic and antiemetic drugs, intentional self-harm

Name of the Condition

• Poisoning by antiallergic and antiemetic drugs, intentional self-harm (ICD-10 code: T45.0X2)

Summary

This condition involves harmful effects resulting from intentional self-harm through exposure to antiallergic (e.g., antihistamines) or antiemetic (e.g., drugs to prevent nausea/vomiting) medications. It reflects deliberate ingestion or exposure to these agents, leading to poisoning or toxic reactions.

Causes

Intentional self-harm may occur due to deliberate overdose of antiallergic or antiemetic drugs. This can involve taking excessive doses, combining these medications with other substances, or using them in a manner inconsistent with therapeutic intent. The underlying motivation often relates to suicidal ideation or self-injurious behavior.

Risk Factors

• History of mental health conditions (e.g., depression, anxiety, or suicidal ideation).
• Access to antiallergic or antiemetic medications in the home or clinical setting.
• Prior episodes of self-harm or substance misuse.
• Social or environmental stressors contributing to impulsive behavior.
• Lack of supervision or support in at-risk individuals.

Symptoms

• Drowsiness, confusion, or altered mental status.
• Tachycardia, hypotension, or cardiac arrhythmias.
• Respiratory depression, shallow breathing, or cyanosis.
• Nausea, vomiting, or abdominal pain.
• Seizures, coma, or other neurological abnormalities.
• Dry mouth, blurred vision, or urinary retention (common with anticholinergic effects).

Diagnosis

Diagnosis relies on a detailed patient history, including intent and circumstances of exposure, clinical assessment of symptoms, and laboratory testing to identify drug levels or metabolites. Physical examination may reveal signs of toxicity, and collateral information (e.g., witness accounts) can confirm intentional self-harm. Psychiatric evaluation is often necessary to address underlying mental health concerns.

Treatment Options

Treatment focuses on stabilizing the patient, removing the toxin, and managing complications. This may include activated charcoal to limit absorption, supportive care (e.g., airway management, intravenous fluids), and specific antidotes if available. Psychiatric intervention and safety planning are critical to address the underlying intent and prevent recurrence.

Prognosis and Follow-Up

Prognosis depends on the severity of poisoning, timeliness of treatment, and underlying mental health status. Early intervention improves outcomes, but severe cases may result in long-term organ damage or mortality. Follow-up includes monitoring for complications, psychiatric care, and coordination with social services to ensure safety and support.

Complications

• Respiratory failure or arrest.
• Cardiac arrhythmias or cardiovascular collapse.
• Seizures or neurological damage.
• Rhabdomyolysis or kidney injury.
• Psychiatric sequelae, including persistent suicidal ideation.
• Repeated self-harm or overdose.

Lifestyle & Prevention

• Secure storage of medications to limit access.
• Education on proper dosing and disposal of unused drugs.
• Regular mental health screening and support for at-risk individuals.
• Encouraging open communication about suicidal thoughts or distress.
• Involvement of family or caregivers in medication management.

When to Seek Professional Help

Seek immediate medical attention if intentional self-harm with antiallergic or antiemetic drugs is suspected or confirmed. Signs of toxicity (e.g., altered consciousness, difficulty breathing, or seizures) require urgent care. Psychiatric evaluation is essential to address intent and prevent future incidents.

Tips for Medical Coders

Document the intent (intentional self-harm) clearly in the medical record, as this distinguishes T45.0X2 from other poisoning codes. Include details about the specific drugs involved, timing of exposure, and clinical findings to support coding accuracy. Ensure alignment with ICD-10-CM guidelines for poisoning and self-harm coding.